Fluoroquinolone Resistance: Mechanisms, Restrictive Dosing, and Anti-Mutant Screening Strategies for New Compounds
- 19 November 2011
- book chapter
- Published by Springer Nature
- p. 485-514
Abstract
No abstract availableKeywords
This publication has 198 references indexed in Scilit:
- Contribution of reactive oxygen species to pathways of quinolone-mediated bacterial cell deathJournal of Antimicrobial Chemotherapy, 2010
- Structural and biochemical characterization of MepR, a multidrug binding transcription regulator of the Staphylococcus aureus multidrug efflux pump MepANucleic Acids Research, 2009
- Actin Homolog MreB Affects Chromosome Segregation by Regulating Topoisomerase IV in Escherichia coliMolecular Cell, 2009
- Multidrug efflux pump overexpression in Staphylococcus aureus after single and multiple in vitro exposures to biocides and dyesMicrobiology, 2008
- A unified anti-mutant dosing strategyJournal of Antimicrobial Chemotherapy, 2008
- Ciprofloxacin-Resistant Enterobacteria Harboring the aac(6 ′ )-Ib-cr Variant Isolated from Feces of Inpatients in an Intensive Care Unit in UruguayAntimicrobial Agents and Chemotherapy, 2008
- Disrupting antibiotic resistance propagation by inhibiting the conjugative DNA relaxaseProceedings of the National Academy of Sciences, 2007
- Transferable Resistance to Aminoglycosides by Methylation of G1405 in 16S rRNA and to Hydrophilic Fluoroquinolones by QepA-Mediated Efflux in Escherichia coliAntimicrobial Agents and Chemotherapy, 2007
- Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coliMolecular Systems Biology, 2007
- Multidrug-resistance efflux pumps ? not just for resistanceNature Reviews Microbiology, 2006